The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.

David Wainer

Columnist for The Wall Street Journal

David Wainer is a Brazilian-American columnist based in New York who writes for the “Heard on the Street” section of The Wall Street Journal, with a primary focus on the business of healthcare, biotech and pharmaceuticals. He holds a bachelor’s degree in finance and brings together financial market insight and health-industry analysis, regularly exploring topics such as insurance trends, drug-maker strategies and longevity science.

Visit website: https://www.wsj.com/news/author/david-wainer

 david-wainer-28127a48

 david_wainer

See also

The Wall Street Journal

One of the world's leading daily financial newspapers

Details last updated 05-Nov-2025

David Wainer News

Biotech’s comeback looks built to last

Biotech’s comeback looks built to last

The Wall Street Journal - 13-Oct-2025

Easing regulations and new drug approvals fuel optimism for a sustained biotech rally

Articles written by David Wainer

Biotech’s comeback looks built to last

Biotech’s comeback looks built to last

The Wall Street Journal - 13-Oct-2025

Easing regulations and new drug approvals fuel optimism for a sustained biotech rally